Bryan Norrie

Partner at Aitken Klee LLP

Bryan Norrie is a partner at Aitken Klee LLP in the Ottawa office.

Mr Norrie specialises in the litigation of pharmaceutical and biotechnology patents. He has a law degree from McGill University and an MSc in neuroscience and biomedical engineering from the University of Alberta. He is also a registered Canadian patent agent.

Mr Norrie enjoys combining his technical and legal expertise to identify creative approaches to complex issues, and he has been ranked or recognised in many leading industry publications, where he has been hailed as a “strong litigator” and “exceptional lawyer” who “has tremendous experience”.

Mr Norrie has extensive experience and success, both in assisting clients in protecting and asserting patent rights, and assisting clients in defending against allegations of patent infringement. Mr Norrie also has considerable experience in regulatory and commercial aspects of patent litigation, including proceedings for judicial review of regulatory administrative decisions, as well as litigation to determine remedies such as damages quantification.

Mr Norrie represented clients in consecutive trials that were conducted by videoconference in late 2020. He obtained successful judgments in both: Teva v Pharmascience, 2020 FC 1158 (representing Teva) and Janssen v Dr Reddy’s, 2021 FC 4 (representing Dr Reddy’s).

Mr Norrie frequently appears in the Federal Court of Canada and Federal Court of Appeal in trials, application hearings, motions and appeals.

Sample client list

  • Dr Reddy’s
  • Natco
  • Teva

Firm details

Aitken Klee LLP
Suite 300
100 Murray Street
Ottawa ON K1N 0A1
Canada

Contact details

See firm profile